Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder (Q46525507)
Jump to navigation
Jump to search
scientific article published in July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder |
scientific article published in July 2005 |
Statements
1 reference
Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder (English)
1 reference
Natalie Ciliberto
1 reference
Cynthia A Bossie
1 reference
Ronald Urioste
1 reference
Robert A Lasser
1 reference
1 July 2005
1 reference
20
1 reference
4
1 reference
207-212
1 reference